BUY TO SELL STOCKS FOR SHORT TERM GAINS
02nd January 2014
PANACEA BIOTEC BUY POTENTIAL UPSIDE: 18.3%
CURRENT MARKET PRICE: 102.30 TARGET PRICE: 121.00
BSE Code 531349 Market Cap (Crores) 626.60
NSE Code PANACEABIO P/E 0
Book Value 91.63 EPS -42.81
Face Value 1 Dividend Yield % -
STOCK RECOMMENDATION
15% @ 90 DAYS – JAN 2014
- 2 - SARAL GYAN CAPITAL SERVICES
Comparative Chart (Last 1 Year) Panacea Biotec & Nifty:
Nifty: 3.5% Panacea Biotec: -9.7%
Stock Resistance and Support:
1st Resistance – 110 1st Support – 98
2nd Resistance – 122 2nd Support – 85
15% @ 90 DAYS – JAN 2014
- 3 - SARAL GYAN CAPITAL SERVICES
Financials at a Glance: Quarterly Results of Panacea Biotec (Rs. In Millions)
Particulars Sep 2013 Jun 2013 Mar 2013 Dec 2012
Audited / UnAudited UA UA UA UA
Net Sales 1100.90 1176.30 1903.60 1841.00
Total Expenditure 1112.40 1277.20 2098.00 2003.90
PBIDT (Excl OI) -11.50 -100.90 -194.40 -162.90
Other Income 2.00 2.50 39.80 25.70
Operating Profit -9.50 -98.40 -154.60 -137.20
Interest 368.20 321.20 357.00 269.80
Exceptional Items 0 0 -105.70 0
PBDT -377.70 -419.60 -617.30 -407.00
Depreciation 185.00 189.60 210.20 215.80
Profit Before Tax -562.70 -609.20 -827.50 -622.80
Tax 0 0 0 0
Provisions and contingencies 0 0 0 0
Profit After Tax -562.70 -609.20 -827.50 -622.80
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0 0 0 0
Net Profit -562.70 -609.20 -827.50 -622.80
Equity Capital 61.30 61.30 61.30 61.30
Face Value (IN RS) 1 1 1 1
Reserves
Calculated EPS -9.18 -9.94 -13.50 -10.16
Calculated EPS (Annualised) -36.72 -39.75 -54.00 -40.64
No of Public Share Holdings 15427192.00 15427192.00 15427192.00 15427192.00
% of Public Share Holdings 25.19 25.19 25.19 25.19
15% @ 90 DAYS – JAN 2014
- 4 - SARAL GYAN CAPITAL SERVICES
Basis of Recommendation:
i) Technical Analysis
Disclaimer: Important Notice: Saral Gyan Capital Services is an Independent Equity Research Company. © SARAL GYAN CAPITAL SERVICES
This Service is provided on an "As Is" basis by saral gyan capital services. Saral gyan capital
services and its affiliates disclaim any warranty of any kind, imputed by the laws of any
jurisdiction, whether express or implied, as to any matter whatsoever relating to the Service,
including without limitation the implied warranties of merchantability, fitness for a particular
purpose. Neither saral gyan capital services nor its affiliates will be responsible for any loss or
liability incurred to the user as a consequence of his or any other person on his behalf taking any
investment decisions based on the above recommendation. Use of the Service is at any persons,
including a Customer's, own risk. The investments discussed or recommended through this
service may not be suitable for all investors. Investors must make their own investment decisions
based on their specific investment objectives and financial position and using such independent
advisors as they believe necessary. Information herein is believed to be reliable but saral gyan
capital services and its affiliates do not warrant its completeness or accuracy. The service should
not be construed to be an advertisement for solicitation for buying or selling of any securities.
Top Related